| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 01/31/2013 | CA2842830A1 Substituted picolinic acids and pyrimidine-4-carboxylic acids, method for the production thereof,and use thereof as herbicides and plant growth regulators |
| 01/31/2013 | CA2841911A1 Substituted 3 - (thiazole - 4 - carbonyl) - or 3 - (thiazole - 2 - carbonyl) - aminopropionic acid derivatives and their use as pharmaceuticals |
| 01/31/2013 | CA2840029A1 Oxazole and thiazole derivatives as selective protein kinase inhibitors (c-kit) |
| 01/30/2013 | EP2550268A1 Analogues for the treatment or prevention of flavivirus infections |
| 01/30/2013 | EP2550266A2 Heterocyclic compounds useful for kinase inhibition |
| 01/30/2013 | EP2550262A1 Analogues for the treatment or prevention of flavivirus infections |
| 01/30/2013 | EP2550258A2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 01/30/2013 | CN102906080A Compounds for the treatment of hepatitis C |
| 01/30/2013 | CN102898424A Novel polymorphs of dasatinib, and preparation method thereof |
| 01/30/2013 | CN102898400A GPR119 agonist and application thereof |
| 01/30/2013 | CN101959883B 3-indazolyl-4-pyridylisothiazoles |
| 01/29/2013 | US8362274 Arylalkylamine compound and process for preparing the same |
| 01/29/2013 | US8362264 Compositions and methods for the treatment of disease associated with Trp-p8 expression |
| 01/29/2013 | US8362037 2-aminopyridine analogs as glucokinase activators |
| 01/29/2013 | US8362035 Crystalline forms of a potent HCV inhibitor |
| 01/29/2013 | US8362032 Bicyclic derivatives as modulators of ion channels |
| 01/29/2013 | US8362025 Compositions useful for treating disorders related to TRPA1 |
| 01/29/2013 | US8362020 Hepatitis C virus inhibitors |
| 01/29/2013 | US8362003 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| 01/29/2013 | US8362001 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 01/29/2013 | CA2694410C Pyridinoylpiperidines as 5-ht1f agonists |
| 01/29/2013 | CA2570673C Compounds and methods for treating dyslipidemia |
| 01/29/2013 | CA2460000C Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 01/24/2013 | WO2013012848A1 Benzamides |
| 01/24/2013 | WO2013012844A1 Arylpyrazole ethers as inhibitors of leukotriene a4 hydrolase |
| 01/24/2013 | WO2013012829A1 Diaminocyclohexane compounds and uses thereof |
| 01/24/2013 | WO2013012827A1 Diaminocyclohexane compounds and uses thereof |
| 01/24/2013 | WO2012010663A9 2,3,5-trisubstituted thiophene compounds and uses thereof |
| 01/24/2013 | US20130023660 Carboxamide Compounds and Methods for Using the Same |
| 01/24/2013 | US20130023543 Human protein tyrosine phosphatase inhibitors and methods of use |
| 01/24/2013 | US20130023542 Human protein tyrosine phosphatase inhibitors and methods of use |
| 01/24/2013 | US20130023534 Pyrazolyl-pyrimidines as kinase inhibitors |
| 01/24/2013 | US20130023528 Prolylhydroxylase inhibitors and methods of use |
| 01/24/2013 | US20130023527 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 01/24/2013 | US20130023526 Isoxazolines as Therapeutic Agents |
| 01/24/2013 | US20130023525 Gyrase inhibitors and uses thereof |
| 01/24/2013 | US20130023522 Benzamides |
| 01/24/2013 | US20130023502 Substituted pyridinyl-pyrimidines and their use as medicaments |
| 01/24/2013 | US20130023497 Triazine Derivatives and their Therapeutical Applications |
| 01/24/2013 | US20130023494 Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| 01/24/2013 | US20130022629 Modulators of Immunoinhibitory Receptor PD-1, and Methods of Use Thereof |
| 01/24/2013 | CA2834199A1 Benzamides |
| 01/23/2013 | EP2548618A2 Organic compounds |
| 01/23/2013 | EP2547676A2 Modulators of hec1 activity and methods therefor |
| 01/23/2013 | EP2547665A1 Insecticidal compounds |
| 01/23/2013 | EP2547664A1 Morpholinylquinazolines |
| 01/23/2013 | EP2547660A1 Nitroxyl (hno) releasing compounds and uses thereof in treating diseases |
| 01/23/2013 | EP2547655A2 Arylsulfonamide ccr3 antagonists |
| 01/23/2013 | CN102892761A 4 - aminopyrimidine derivatives and their as as adenosine a2a receptor antagonists |
| 01/23/2013 | CN102892754A Arylsulfonamide ccr3 antagonists |
| 01/23/2013 | CN102892290A Noxious organism control agent |
| 01/23/2013 | CN102887892A 4-tertiary butyl-2-(2-fluorophenylamino)-5-(1,2,4-triazole-1-yl) thiazole crystals |
| 01/23/2013 | CN102887891A N4-phenyl-quinaz0line-4 -amine derivatives and related compounds |
| 01/23/2013 | CN101595105B 2-substituted 5-membered heterocycles as SCD inhibitors |
| 01/23/2013 | CN101591530B Fluorescent probe for detecting glutathione reductase and bioactive sulfhydryl compound as well as synthesis method and application thereof |
| 01/23/2013 | CN101573357B 吲哚化合物 Indole compound |
| 01/22/2013 | US8357702 Bicyclic derivatives as modulators of voltage gated ion channels |
| 01/22/2013 | US8357683 Compounds for enzyme inhibition |
| 01/22/2013 | US8357524 Chemically modified mutant serine hydrolases show improved catalytic activity and chiral selectivity |
| 01/22/2013 | CA2725810C Tetomilast polymorphs |
| 01/22/2013 | CA2650932C Substituted spirocyclic cgrp receptor antagonists |
| 01/17/2013 | WO2013008091A1 Manufacturing of epothilone derivatives and the use thereof |
| 01/17/2013 | WO2013007792A1 Novel th2 polarizing compounds |
| 01/17/2013 | WO2013007676A1 Aminomethyl quinolone compounds |
| 01/17/2013 | WO2013007184A1 Antineoplastic drug tetrahydronaphthalene amide-group compound and pharmaceutically acceptable salt, preparation method and use thereof |
| 01/17/2013 | WO2013007168A1 Preparation and use of pyrrole and dihydropyrrole fused ring compound having insecticidal activity |
| 01/17/2013 | WO2012068234A3 Antiviral compounds |
| 01/17/2013 | US20130019348 Pesticidal compositions and processes related thereto |
| 01/17/2013 | US20130018075 Heterocyclic inhibitors of mek and methods of use thereof |
| 01/17/2013 | US20130018048 Oxazole derivatives useful as modulators of faah |
| 01/17/2013 | US20130018039 Imidazolyl-imidazoles as kinase inhibitors |
| 01/17/2013 | US20130018031 Aminoalkylpyrimidine derivatives as histamine h4 receptor antagonists |
| 01/17/2013 | US20130017196 Substituted imidazole derivatives |
| 01/17/2013 | CA2839395A1 Aminomethyl quinolone compounds |
| 01/16/2013 | EP2546253A1 Substituted dihydropyrazolones for the treatment of cardiovascular and hematological diseases |
| 01/16/2013 | EP2546252A1 Heteroaryl-substituted 1,3 dihydroindol-2-one derivatives and medicaments containing them |
| 01/16/2013 | EP2546251A1 Heteroaryl-substituted 1,3 dihydroindol-2-one derivatives and medicaments containing them |
| 01/16/2013 | EP2546250A1 Heteroaryl-substituted 1,3 dihydroindol-2-one derivatives and medicaments containing them |
| 01/16/2013 | EP2546242A1 Cannabinoid receptor ligands |
| 01/16/2013 | EP2546241A1 Cannabinoid receptor ligands |
| 01/16/2013 | EP2546232A1 Diphenyl Substituted Alkanes |
| 01/16/2013 | EP2545049A1 Crystalline salts of a potent hcv inhibitor |
| 01/16/2013 | EP2545046A1 N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof |
| 01/16/2013 | EP2545042A1 Compounds for the treatment of hepatitis c |
| 01/16/2013 | EP2545041A1 Bioluminescent assays using cyanobenzothiazole compounds |
| 01/16/2013 | EP2545037A1 Inhibitors of protein kinases |
| 01/16/2013 | EP2544684A1 4,4-disubstituted piperidine derivatives useful as inhibitors of dipeptidyl peptidase-1 (dpp-1) |
| 01/16/2013 | EP2281822B1 New dihydroindolone derivatives, method of preparing same and pharmaceutical compositions containing them |
| 01/16/2013 | CN102884156A Light-emitting device material and light-emitting device |
| 01/16/2013 | CN102884062A Aminopyrimidine kinase inhibitors |
| 01/16/2013 | CN102884061A Method of making coupled heteroaryl compounds via rearrangement of halogenated heteroaromatics followed by oxidative coupling |
| 01/16/2013 | CN102884059A N-酰基环胺衍生物或其可药用盐 N- acyl cyclic amine derivative or pharmaceutically acceptable salt thereof |
| 01/16/2013 | CN102884052A Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 01/16/2013 | CN102875543A 4-tertiary butyl-5-(1, 2, 4-triazole-1-base)-2-aminothiazole preparation method |
| 01/16/2013 | CN102872012A Compound capable of inhibiting protein kinase and application thereof |
| 01/16/2013 | CN101747253B Trisubstituted chiral lactam derivative and preparation method and application thereof |
| 01/16/2013 | CN101405270B Pyrazoles as 11-beta-HSD-1 |
| 01/16/2013 | CN101392174B Soluble electro-green light organic molecule glass material and preparation method and use thereof |
| 01/15/2013 | US8354540 2-aminopyridine analogs as glucokinase activators |
| 01/15/2013 | US8354531 Compounds for the treatment of inflammatory diseases |